Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Generic EpiPen Cost; Amazon's Medical Software; European Report on Curbing Spending
November 28, 2018 – AJMC Staff
What We're Reading: Michigan Drug Pricing Experiment; ACA Enrollment; Gun Laws and Gun Deaths
November 15, 2018 – AJMC Staff
27% of Families Delay Medical Care Due to Costs
November 09, 2018 – Jaime Rosenberg
Saving Costs While Maintaining Quality of Care—The Value of Biosimilars in Oncology
November 08, 2018 – Surabhi Dangi-Garimella, PhD
What We're Reading: HPV Vaccine Use; $4 Million Drug; ACS Fundraising Concerns
November 06, 2018 – AJMC Staff
What We're Reading: Biosimilar Rituximab; Turning Back Time on EHRs; OTC Cough Products for Kids
November 05, 2018 – AJMC Staff
This Week in Managed Care: November 2, 2018
November 02, 2018
This Week in Managed Care: October 26, 2018
October 26, 2018
Trump Proposes Allowing Medicare to Base Drug Prices on What Other Countries Pay
October 25, 2018 – Laura Joszt

What We're Reading: Generic EpiPen Cost; Amazon's Medical Software; European Report on Curbing Spending

AJMC Staff
A generic competitor to the EpiPen will not cost any less than the version that is already on the market; a new service from Amazon will use machine learning to pull key information from patient records; a new report from the European Commission has noted that generic and biosimilar products will be key to curbing wasteful spending in healthcare.

No Savings on Generic EpiPen

A generic competitor to the EpiPen will not cost any less than the version that is already on the market. According to The Hill, Teva’s generic drug will be available in limited quantities for $300, the same price as Mylan’s version. Since 2007, the price of the EpiPen has risen from less than $100 for a pack of 2 injectors to more than $600. Mylan sells an authorized generic for $300. FDA Commissioner Scott Gottlieb, MD, has said that bringing more generics to the market will help bring the cost down, but he also acknowledged that the agency cannot control commercial pricing decisions.

 

Amazon’s New Software Will Mine Patient Records for Data

A new service from Amazon will use machine learning to pull key information from patient records. Amazon Comprehend Medical can pick out and organize information about diagnoses, treatments, medication dosages, and symptoms in order to help providers make treatment decisions, according to TechCrunch. Amazon has said the software complies with the Health Insurance Portability and Accountability Act, known as HIPAA, and that patient data is encrypted and can only be unlocked by customers who have a key.

 

European Report Highlights Importance of Generics, Biosimilars

A new report from the European Commission has noted that generic and biosimilar products will be key to curbing wasteful spending in healthcare. The Center for Biosimilars®, a sister site of The American Journal of Managed Care®, reported that nearly one-fifth of health spending is considered wasteful, and in 2016, it was estimated that biosimilars could save up to $113 billion by 2020 in Germany, France, Italy, Spain, and the United Kingdom. The report identifies 4 approaches to curb wasteful health spending, including fully exploiting potential savings from generics and biosimilars.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up